Pharmaceutical Research and Manufacturers of America (PhRMA) has named Anne Esposito as senior vice president of federal advocacy, effective January 2020. Ms. Esposito will oversee the association’s federal government affairs and succeeds Scott Olsen, who is retiring. 

“Anne’s extensive experience provides her with the strategic leadership needed to build upon our successful advocacy to advance public policy reforms that address patient affordability challenges and foster innovation,” said PhRMA president and CEO Stephen J. Ubl. “Her ability to work on a bipartisan basis with stakeholders across the health care system is a vital addition to the association.”  

Ms. Esposito is a seasoned government relations strategist with more than 20 years of policy and political expertise in the public and private sector. Following several years at the U.S. Department of Health and Human Services, she went to Capitol Hill where she advised members of Congress on health policy and other issues. She has held leadership positions at several large and small biopharmaceutical companies, and most recently served as vice president of global government affairs for Indivior Inc.  

“I look forward to engaging with policymakers and leading the established, talented federal team at PhRMA to advance bipartisan solutions to the health care challenges facing America today,” said Esposito. “I am grateful for this opportunity and excited to support the biopharmaceutical industry and its critical role in developing new life-saving and life-changing therapies.”